Canada approves Moderna how to improve COVID-19 vaccination: official

The COVID-19 anticoagulant drug was developed by the American biotech company Moderna me, and the label was released on Wednesday, two days after the drug was treated at Pfizer / BioNTech. “Canadian health … has decided that Moderna medicine is meeting the Department’s strict storage, performance and quality,” the section said in an upgrade.